Sangeeta N. Bhatia
Founder of Ropirio Therapeutics
Cambridge, Massachusetts
Overview
Work Experience
Professor, Director Marble Center for Cancer Nanomedicine
2005 - Current
Co-Founder
2023
Co-Founder
2023
Co-Founder
2022
Co-Founder
2020
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Raised $101,470,989.00 from Section 32, aMoon Fund, Polaris Partners, Waterman Ventures, Lightspeed Venture Partners, Alumni Ventures and Catalio Capital Management.
Co-Founder
2015
Fellow, Board of Trustees
2015
Member Board of Directors
2015
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Raised $657,308,360.00 from J.P. Morgan Securities Inc., Bank of America Merrill Lynch, Morgan Stanley, Goldman Sachs and Janssen Belgium.
Co-Founder, Hepregen
2008 - 2018
BioIVT is a worldwide provider of biological and in vitro products to pharmaceutical and biotechnology organizations
Raised $45,000,000.00 from Thompson Street Capital Partners and NXT Capital.
Member, Board of Scientific Advisors
2013 - 2017
Technology Transfer Center (TTC) facilitates partnerships between the NIH research laboratories and external partners.